Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patientsOlle Stål|British Journal of Cancer|2002Cited by 393
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefitJosefine Bostner, Olle Stål|Breast Cancer Research and Treatment|2012Cited by 99
Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast CancerJosefine Bostner, Olle Stål|Clinical Cancer Research|2010Cited by 58
S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohortsJosefine Bostner, Olle Stål|Endocrine Related Cancer|2015Cited by 34
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancerPiiha-Lotta Jerevall, Olle Stål|Breast Cancer Research|2010Cited by 34